Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases
Source : https://pubmed.ncbi.nlm.nih.gov/38598571/
The omission of completion axillary-lymph-node dissection was noninferior to the more extensive surgery in patients with clinically node-negative breast cancer who had sentinel-node macrometastases, most of whom received nodal radiation...
The estimated 5-year recurrence-free survival were 89.7% in the sentinel-node biopsy-only and 88.7% in the dissection groups, with a country-adjusted HR for recurrence or death of 0.89.
-
Albert Dekker1yrit is obviously important to take in consideration pretreatment number of LN and the overall risk of disease
Hypofractionated Partial Breast Irradiation With Intensity-Modulated Radiotherapy in Early Breast Cancer or Carcinoma In Situ: an Investigational Short-Term Analysis
Source : https://ejbc.kr/DOIx.php?id=10.4048/jbc.2023.0296
Kang NK, et al. J Breast Cancer. 2024 Mar;27:e11. https://doi.org/10.4048/jbc.2023.0296
The 2-year disease-free and OS rates were 94.0% and 99.8%, respectively.
Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer
Source : https://pubmed.ncbi.nlm.nih.gov/38517439/
These findings suggest that there were clinical, pathological, and epidemiological differences between ERBB2-low and ERBB2-negative BC, raising the possibility that ERBB2-low might be a unique biologic entity.
These findings suggest that there were clinical, pathological, and epidemiological differences between ERBB2-low and ERBB2-negative breast cancer, raising the possibility that ERBB2-low might be a unique biologic entity.
Metastasis of Serous Ovarian Carcinoma to the Breast: a Case Report and Review of the Literature
Source : https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-024-04445-y
Background Breast metastasis from primary ovarian cancer is rare, with an estimated frequency of 0.07%. More than 110 cases are reported in the literature of metastatic spread of ovarian cancer...
Radiotherapy is a feasible option for local control of metastatic disease to the breast with minimal toxicity and an excellent treatment response which positively impacts quality of life.
The intervention, which was delivered via telephone over 9 sessions, resulted in greater improvements in self-selected activity participation but did not otherwise accelerate recovery compared with the control condition.